Wellcome awards Cambridge £18 million for two Discovery Research Platforms
04 May 2023Cambridge has been awarded two of Wellcome’s eight new Discovery Research Platforms, the global charitable foundation announced today.
Cambridge has been awarded two of Wellcome’s eight new Discovery Research Platforms, the global charitable foundation announced today.
Eight Cambridge researchers - six from the University of Cambridge and two from the MRC Laboratory of Molecular Biology - are among the 63 scientists from around the world elected this year as Members and Associate Members of the European Molecular Biology Organisation (EMBO).
In the first genome-scale experiment of its kind, researchers have gained new insights into how a mouse embryo first begins to transform from a ball of unfocussed cells into a small, structured entity. Published in Nature, the single-cell genomics study was led by the European Bioinformatics Institute (EMBL-EBI) and the University of Cambridge.
The first comprehensive computer model to simulate the development of blood cells could help in the development of new treatments for leukaemia and lymphoma, say researchers at the University of Cambridge and Microsoft Research.
A community science initiative – HAEMCODE – has been welcomed for its contribution to our understanding of blood cells and ultimately, to the development of better treatments for leukaemia.